"The order reimposes a restriction on mifepristone, the first of a two-drug regimen to end a pregnancy, that requires patients pick up the pill at a healthcare facility."
"Telehealth abortion accounts for more than a quarter of all abortions and has been growing in popularity since the Covid-19 pandemic and the US Supreme Court overturned Roe v. Wade."
"Louisiana brought the lawsuit against the Food and Drug Administration in October of last year, arguing that the agency acted unlawfully when it lifted a restriction on mifepristone."
"Prior to Louisiana's lawsuit, a group of anti-abortion doctors pursued the same outcome in addition to asking the FDA to remove its 2000 approval of the drug."
The Fifth Circuit's recent order reinstates a requirement for patients to pick up mifepristone at healthcare facilities, effectively banning telehealth for medication abortions. Telehealth abortion has gained popularity, especially post-Covid-19 and following the overturning of Roe v. Wade. The lawsuit, Louisiana v. FDA, challenges the FDA's previous decision to lift restrictions on mifepristone. Anti-abortion activists have consistently sought to limit access to medication abortion, with Louisiana's lawsuit representing a continuation of these efforts.
Read at The Nation
Unable to calculate read time
Collection
[
|
...
]